Weifa
| Allmennaksjeselskap | |
| Traded as | : |
| Industry | Pharmaceutical |
| Founded | 1940 |
| Headquarters | Oslo, Norway |
| Revenue | 500mill NOK (2012) |
|
Number of employees
|
99 |
| Website | www.weifa.no |
Weifa is a Norwegian pharmaceutical company headquartered in Oslo with production facilities in Kragerø.
Weifa is one of the world’s largest producers of Metformin hydrochloride and a leading producer of alkaloid opiates. Production facilities follow GMP standards.
Weifa was founded by pharmacist Olaf Weider in 1940.
Weifa focuses on three therapeutic areas:
With a total of over 99 employees, Weifa is today generating an annual turnover of approximately €40 million (35% of the turnover is achieved internationally). Weifa bases its development on 3 criteria:
Weifa has market leadership in pain management products for the Norwegian market, with a portfolio of branded products that includes established brand names such as the Ibux tablets, Paracet tablets and Paralgin Forte tablets. Branded products accounts for approximately 70% of net sales.
Weifa’s leading export markets are Germany and United Kingdom. Besides these two essential export markets, Weifa has a long-standing presence in all the main countries of the European Union, in Eastern Europe, in Africa, in North America, in South America and in Asia.
...
Wikipedia